Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EMvision Medical DevicesASX:EMV -5.23%20 EV-to-EBIT is -14.18 as of Jul. 26, 2026. GuruFocus rates ASX:EMV with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 467 Medical Devices & Instruments companies, EMvision Medical Devices ranks worse than 214132.55% on this metric.
The historical rank and industry rank for EMvision Medical Devices's EV-to-EBIT or its related term are showing as below:
ASX:EMV'
s EV-to-EBIT Range Over the Past 10 Years
Min: -14.18 Med: 0 Max: 0
Current: -14.18
ASX:EMV's EV-to-EBIT is ranked worse than 100% of 467
companies
in the Medical Devices & Instruments industry
Industry Median: 18.21
vs ASX:EMV: -14.18
EMvision Medical Devices (ASX:EMV) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
EMvision Medical Devices's Enterprise Value for the quarter that ended in Dec. 2025 was A$151.35 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. EMvision Medical Devices's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-9.10 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EMvision Medical Devices EV-to-EBIT Related Terms
EMvision Medical Devices EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, EMvision Medical Devices's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
EMvision Medical Devices EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, EMvision Medical Devices's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where EMvision Medical Devices's EV-to-EBIT falls into.
EMvision Medical Devices's current Enterprise Value is A$129.05 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. EMvision Medical Devices's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was A$-9.10 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EMvision Medical Devices (ASX:EMV) has a EV-to-EBIT of -14.18 as of Jul. 26, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on EMvision Medical Devices and its competitors. According to the industry distribution chart, EMvision Medical Devices ranks #999999 out of 467 companies in the Medical Devices & Instruments industry.
Is EMvision Medical Devices' EV-to-EBIT too high?
EMvision Medical Devices' current EV-to-EBIT is -14.18. Based on the distribution chart, EMvision Medical Devices ranks #999999 out of 467 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, EMvision Medical Devices has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does EMvision Medical Devices' EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, EMvision Medical Devices ranks #999999 out of 467 companies for EV-to-EBIT. This places EMvision Medical Devices in the lower half of its industry. The industry median EV-to-EBIT is 18.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.21, based on 467 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on EMvision Medical Devices and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. EMvision Medical Devices's current EV-to-EBIT is -14.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EMvision Medical Devices stock overvalued right now?
EMvision Medical Devices (ASX:EMV) has a current EV-to-EBIT of -14.18. The current EV-to-EBIT is -14.18. EMvision Medical Devices' overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For EMvision Medical Devices (ASX:EMV), the current EV-to-EBIT is -14.18 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury.
20GF Score
Get the complete analysis for ASX:EMV
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:EMV has been successfully added to your 
